Immediate Impact

1 by Nobel laureates 50 standout
Sub-graph 1 of 25

Citing Papers

Aspirin for Metabolic Dysfunction–Associated Steatotic Liver Disease Without Cirrhosis
2024 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
2 intermediate papers

Works of Eisuke Nagata being referenced

Comparison of Liver Histology Between Patients with Non‐Alcoholic Steatohepatitis and Patients with Alcoholic Steatohepatitis in Japan
2005
Nateglinide is useful for nonalcoholic steatohepatitis (NASH) patients with type 2 diabetes.
2005

Author Peers

Author Last Decade Papers Cites
Eisuke Nagata 193 57 72 144 19 331
Pir Ahmad Shah 170 48 69 118 22 304
Tetsuharu Oriishi 147 85 58 95 20 342
Kevin A. Lang 180 149 56 125 15 336
Elisabetta Morello 224 57 111 124 14 370
Kazuya Okushin 204 117 82 74 27 353
Y Liu 173 65 86 54 13 363
Valentina Monti 189 88 43 191 17 340
Howard H.W. Leung 188 24 36 131 25 272
Lance L. Stein 198 77 65 148 19 339
Hiroaki Hashizume 200 116 59 146 15 304

All Works

Loading papers...

Rankless by CCL
2026